Human endogenous retrovirus type W (HERV-W)

Human endogenous retrovirus type W (HERV-W) is a family of endogenous retroviral sequences that account for roughly 1% of the human genome, integrated as a result of ancient infections by exogenous retroviruses. Most loci are replication-defective, but at least one (ERVWE1) retains an open reading frame encoding the envelope (Env) protein known as Syncytin-1, which is essential for placental syncytiotrophoblast formation. Abnormal expression of HERV-W-encoded proteins, especially the Env protein (including MSRV-Env), has been implicated in neuroinflammatory and autoimmune conditions such as multiple sclerosis, acting through induction of cytokine responses and neuroinflammation. HERV-W elements are also under investigation for their potential involvement in cancer and other diseases, though causality remains unproven. The HERV-W-Env protein is an emerging therapeutic target, with antibodies under clinical development, but targeting these pathways carries risks due to physiological roles in placental development and possible immune system effects [1][3][4].

Other names

Human endogenous retrovirus-WHERV-WEndogenous retrovirus group WERVW-1 (for the gene)Syncytin-1 (for protein product of specific locus ERVWE1)MSRV (multiple sclerosis-associated retrovirus, a related locus/protein)HERV-W-Env (for the envelope gene/protein)Enverin (alternate protein name)HERV-7qHERV7Q

Neutralization of HERV-W-Env protein (by monoclonal antibody); Downregulation of pro-inflammatory response (via blocking the Env protein's effect on immune cells); Inhibition of syncytia formation (when targeting Syncytin-1 in placental or pathological contexts)